1 / 6

Global Breast Cancer Market 2014-2018

Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer and other undifferentiated carcinoma. Ductal carcinoma is the form of breast cancer which starts in the lining of the milk ducts while lobular carcinoma begins in the milk glands of the breast. When breast cancer spreads from the site of origin to surrounding tissue, it is known as invasive breast cancer. Invasive ductal carcinoma is the most common subtype accounting for 70 to 80 percent of all the breast cases. In women, breast cancer is the second most common form of cancer. GLOBOCAN reported that in the year 2012, breast cancer accounted for 11.9 percent of the total cancer cases and lead to 5,22,000 deaths worldwide. Get access to detailed report at: http://www.researchbeam.com/global-breast-cancer-2014-2018-market

Florence_2012
Download Presentation

Global Breast Cancer Market 2014-2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Breast Cancer Market 2014-2018 Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2018 • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com

  2. Report overview Research Beam adds a report titled “Global Breast Cancer Market 2014-2018“ that provides latest Market Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast. Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer and other undifferentiated carcinoma. Ductal carcinoma is the form of breast cancer which starts in the lining of the milk ducts while lobular carcinoma begins in the milk glands of the breast. When breast cancer spreads from the site of origin to surrounding tissue, it is known as invasive breast cancer. Invasive ductal carcinoma is the most common subtype accounting for 70 to 80 percent of all the breast cases. In women, breast cancer is the second most common form of cancer. GLOBOCAN reported that in the year 2012, breast cancer accounted for 11.9 percent of the total cancer cases and lead to 5,22,000 deaths worldwide. As per the Report, Global Breast Cancer market will grow at a CAGR of 11.61 percent over the period 2014-2018. This report covers the present scenario and the growth prospects of the Global Breast Cancer market for the period 2014-2018.  Get access to detailed report at: http://www.researchbeam.com/global-breast-cancer-2014-2018-market

  3. Report overview To calculate the market size, the report considers revenue generated through the sale of drugs used for the management of breast cancers including but not limited to:• HER2-negative breast cancer• HER2-positive breast cancer• Hormone receptor positive breast cancer• Hormone receptor negative breast cancer• Advanced breast cancer • Early breast cancer• Operable node positive breast cancer• Metastatic breast cancer• Triple Negative Breast Cancer The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the Global Breast Cancer market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The Global Breast Cancer Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Breast Cancer market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

  4. Report overview Key Regions• Americas • EMEA        • APAC Key Vendors• Astrazeneca PLC • Eli Lilly and Company• F. Hoffmann-La Roche Ltd• Novartis AG• Sanofi-Aventis Other Prominent Vendors• Accord Healthcare, Inc. • Pfizer, Inc.• Hospira, Inc.• Actavis, Inc.• Bayer AG• BioMarin Pharmaceutical Inc.• Bristol-Myers Squibb Company Enquire about report @: http://www.researchbeam.com/global-breast-cancer-2014-2018-market/enquire-about-report

  5. Table of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Treatment Regimen for Breast Cancer 08. Market Segmentation by Type of Therapy 09. Market Segmentation by Molecule Type 10. Global Monoclonal Antibodies Market in Breast Cancer 11. Clinical Pipeline Portfolio 12. Geographical Segmentation 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 21. Key Vendor Analysis

  6. FOR MORE DETAILS Visit us at : http://www.researchbeam.com/global-breast-cancer-2014-2018-market • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States Stay With Us:

More Related